<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2600">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04474249</url>
  </required_header>
  <id_info>
    <org_study_id>EPM-2020-02697</org_study_id>
    <nct_id>NCT04474249</nct_id>
  </id_info>
  <brief_title>Follow-up of Critical COVID-19 Patients</brief_title>
  <acronym>FUP-COVID</acronym>
  <official_title>Uppföljning av Patienter Som intensivvårdats för COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Uppsala University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will follow COVID-19 patients who required intensive care after 3-6 months and one
      year after discharge from the ICU with functional level as well as organ function to assess
      recovery after COVID-19. Blood and urine will be collected for biobanking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will follow COVID-19 patients who required intensive care at Uppsala University
      Hospital and were included in the Uppsala COVID-19 biobank. The patients will be contacted
      after three to six months for a first follow-up with assessment of functional level in
      activities of daily life, psychiatric symptoms, neurological symptoms and working capacity as
      well as specific organ functions. The organ functions will include circulation, respiration,
      coagulation, immune function and kidney function. In addition, blood and urine will be
      collected for biobanking.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Within 90 days after admission to ICU.</time_frame>
    <description>Death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Within 1 year after admission to ICU.</time_frame>
    <description>Death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal recovery</measure>
    <time_frame>At follow-up three to six months after ICU discharge.</time_frame>
    <description>Return of renal function measured as CKD stage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal recovery</measure>
    <time_frame>At follow-up one year after ICU discharge.</time_frame>
    <description>Return of renal function measured as CKD stage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory recovery</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Respiratory function as assessed by a clinician</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Working capacity</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>6 min walk test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life score</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Quality of Life assessed using the 36-item short form survey by RAND.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive recovery</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Cognitive screening using the Montreal Cognitive Assessment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Frailty</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Screening for frailty using the Clinical Frailty Scale-9.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Activities of Daily Life</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Screening of functional level for Activities of Daily Life using the 5-level EQ-5D.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anxiety</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Screening for anxiety using the Generalised Anxiety Disorder 7-item scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Depression</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Screening for depression using the Patient Health Questionnaire 9.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurological recovery</measure>
    <time_frame>Three to six months from discharge from ICU</time_frame>
    <description>Neurological function as assessed by a clinician</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>COVID19</condition>
  <condition>ARDS</condition>
  <condition>AKI</condition>
  <condition>Circulatory Failure</condition>
  <condition>Coagulation Disorder</condition>
  <condition>Inflammatory Response</condition>
  <arm_group>
    <arm_group_label>COVID-19</arm_group_label>
    <description>Patients with PCR-confirmed COVID-19 who were treated in the intensive care unit.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine, Whole blood, Dried blood, Serum, EDTA-plasma, Citrate-plasma, cheek swab.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients admitted to ICU for COVID-19.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PCR-verified Covid-19

          -  Treated in ICU

        Exclusion Criteria:

          -  Pregnant of breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Hultström, MD. PhD.</last_name>
    <phone>+46186110000</phone>
    <email>michael.hultstrom@mcb.uu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Frithiof, MD. PhD.</last_name>
    <phone>+46186110000</phone>
    <email>robert.frithiof@surgsci.uu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Hultström, MD. PhD.</last_name>
      <phone>+46186110000</phone>
      <email>michael.hultstrom@mcb.uu.se</email>
    </contact>
    <contact_backup>
      <last_name>Robert Frithiof, MD. PhD.</last_name>
      <phone>+46186110000</phone>
      <email>robert.frithiof@surgsci.uu.se</email>
    </contact_backup>
    <investigator>
      <last_name>Miklos Lipcsey, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Hultström, MD. PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Frithiof, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sten Rubertsson, MD. PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ewa Wallin, PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ing-Marie Larsson, PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 29, 2020</study_first_submitted>
  <study_first_submitted_qc>July 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Corona virus</keyword>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>SARS</keyword>
  <keyword>Vasopressor</keyword>
  <keyword>Respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Shock</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Data will be shared on reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

